Objective: Arterial thoracic outlet syndrome (TOS) is a rare condition characterized by subclavian artery pathology associated with a bony abnormality. This study assessed contemporary clinical management of arterial TOS at a highvolume referral center.
One hundred years ago, Dr William Halsted presented the first large collected clinical series of patients with subclavian artery aneurysms in association with cervical rib anomalies. 1 He and others subsequently investigated the unique pathophysiologic implications of this relationship and defined poststenotic dilatation as a distinct mechanism of aneurysm formation. [2] [3] [4] Subclavian artery aneurysms and other pathologic lesions are now recognized as part of the spectrum of conditions known as thoracic outlet syndrome (TOS), which includes brachial plexus compression (neurogenic TOS) and subclavian vein effort thrombosis (venous TOS). 5 Arterial TOS is the least frequent form of these conditions, but its clinical presentation is distinguished by the potential for life-and limb-threatening thromboembolic complications. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] In 2008 we established a multidisciplinary center approach to focus on TOS to standardize and optimize protocols for the evaluation and treatment of all forms of TOS. The purpose of this study was to assess the presenting characteristics and contemporary management of arterial TOS at a single high-volume referral center. 17, 18 
METHODS
All patients in this study gave informed consent for the publication of their medical data through a protocol approved by the Human Research Protection Office at Washington University in St. Louis, St. Louis, Mo.
Patient population, inclusion and exclusion criteria.
Patients treated for arterial TOS were identified using a prospectively maintained database of all patients treated at the Washington University in St. Louis Center for Thoracic Outlet Syndrome at Barnes-Jewish Hospital, St. Louis, Mo, from January 2008 through December 2016. Arterial TOS was defined as the existence of subclavian artery pathology (aneurysmal dilatation, occlusion, stenosis, or embolizing ulceration) in the presence of a congenital or acquired bony abnormality within the thoracic outlet. These bony abnormalities included congenital cervical rib or hypoplastic first rib anomalies and acquired fractures of the clavicle or first rib, as evident on plain radiographic studies before the operation.
The study excluded patients with subclavian artery pathology not associated with a bony abnormality and patients with compressive arterial lesions confined to the axillary artery or its branches. Patients presenting with symptoms of neurogenic TOS associated with a bony abnormality who were subsequently found to have coincident subclavian artery pathology were included, as were patients with incidentally identified asymptomatic subclavian artery lesions in the presence of a previously unrecognized bony abnormality. Patients with a clinical examination demonstrating neurogenic TOS and only positional compression of the subclavian artery were excluded, as were patients with neurogenic TOS accompanied by peripheral (hand or finger) vasoconstriction caused by sympathetic overactivity but with no subclavian artery pathology.
Clinical management protocol. Patients presenting with acute upper extremity ischemia were treated with urgent brachial artery thromboembolectomy, with or without adjunctive thrombolytic therapy, at our medical center or at the hospital of origin, followed by maintenance anticoagulation and evaluation for subclavian artery pathology and arterial TOS. Those found to have arterial TOS underwent surgical treatment, typically within several days to weeks of their initial presentation. Asymptomatic individuals and patients presenting with neurogenic TOS who were found to have bony abnormalities and overt subclavian artery lesions underwent elective surgical treatment for arterial TOS. Radiographic assessment for bony abnormalities included anterior-posterior chest x-ray imaging and computed tomography (CT) scans. Assessment of the subclavian artery was performed using contrastenhanced magnetic resonance angiography (MRA), CT angiography (CTA) with three-dimensional image reconstruction, or direct catheter-based arteriography. 19 Surgical treatment. Surgical treatment for arterial TOS consisted of supraclavicular thoracic outlet decompression with complete anterior and middle scalenectomy, brachial plexus neurolysis, and resection of the cervical rib and first rib. 20 Direct surgical repair of the subclavian artery was performed in the same operation for subclavian artery aneurysms with a diameter 100% greater than the unaffected proximal subclavian artery, embolizing lesions, or for thrombotic occlusion, but repair was not performed for poststenotic subclavian artery dilatation <100%. When distal control of the subclavian artery could not be obtained from the supraclavicular incision alone, a lateral infraclavicular incision was added for exposure and control of the axillary artery. 21 For arterial repair, the distal anastomosis was performed first, followed by the proximal anastomosis, by using end-to-end interposition grafting technique. The preferred conduits for repair included cryopreserved femoral artery, cryopreserved femoral vein, or woven Dacron (DuPont, Wilmington, Del).
Outcomes measures. Hospital length of stay and postoperative complications were recorded. Clinical assessment of the results for arterial reconstruction included examination for any evidence of digital emboli or ischemia, bilateral upper extremity blood pressures, and pulse waveforms on noninvasive vascular laboratory testing or imaging studies (MRA, CTA, or catheterbased arteriography), when indicated. Outcomes were also assessed using several patient-reported survey instruments previously used in the assessment of patients with TOS, including the 11-item version of the Disability of the Arm, Shoulder and Hand (QuickDASH) Outcome Measure (scale 0-100), the Cervical-Brachial Symptom Questionnaire (CBSQ; scale 0-100), and the McGill Pain Questionnaire, which includes a 10-point visual analog scale for pain, the Pain Rating Index, and the Overall Pain Intensity instruments, and is assessed on a 0-100 scale. 22 Statistical analysis. Descriptive data are reported as the group percentage or the mean 6 standard error of the mean. Patient-reported outcomes measures were Recommendation: This study suggests a distinct surgical protocol to achieve excellent outcomes for patients with arterial thoracic outlet syndrome. compared using two-tailed, unpaired t-tests with the Welch correction. Analyses were conducted using Prism 6.0 software (GraphPad Software, Inc, La Jolla, Calif). For all tests, a P value of <.05 was considered to be statistically significant.
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RESULTS
Clinical presentation. Forty patients underwent surgical treatment for arterial TOS from 2008 to 2016, representing 3% of 1401 patients treated for all forms of TOS during the same interval (Fig 1) . Patients were a mean age of 40.3 6 2.2 years (range, 13-68 years), and 72% were women (Table I) . Vascular complications were present in 23 patients (58%), either upper extremity ischemia/ emboli (n ¼ 21) or posterior stroke (n ¼ 2), including eight who had recently required urgent brachial artery thromboembolectomy (3 with adjunctive use of thrombolytic therapy; Fig 2) . The presentation was nonvascular in 17 patients (42%), including 11 with primary symptoms of neurogenic TOS and six with an asymptomatic neck mass or incidentally discovered subclavian artery dilatation, which had led to the recognition of subclavian artery pathology in association with a bony abnormality. A cervical rib was identified by preoperative radiographic studies in 30 patients (75%), with no difference between patients with a vascular (74%) or nonvascular (76%) presentation (Fig 3) .
Surgical treatment. All patients underwent thoracic outlet decompression. A supraclavicular approach alone was used in 25 (65%), and a combined supraclavicular and infraclavicular (paraclavicular) approach was used in 15 (35% ; Table II ). There were 30 patients (75%) with a cervical rib (24 complete, 6 partial), 5 with a first rib abnormality, 4 with a clavicle fracture, and 1 with no bony abnormality (a reoperative procedure in which the cervical and first ribs had been previously removed). Nineteen patients (48%) had a large post-stenotic subclavian artery aneurysm, 7 (17%) had thrombosis of the subclavian artery, and 11 (28%) had poststenotic subclavian artery dilatation that did not meet the threshold for reconstruction (maximal extent of dilatation was <100% of the normal proximal artery).
As reported in Table III , operative treatment included complete anterior and middle scalenectomy in all patients and bone resection in 36 (90%), including combined resection of a cervical rib and first rib in 29 (72%), resection of a first rib alone in 6 (15%), and resection of a cervical rib alone in 1 (2%). Direct subclavian artery reconstruction was performed in 28 patients (70%), with resection and interposition bypass grafting in 26 (65%) using cryopreserved femoral artery in 12 (30%), cryopreserved femoral vein in 10 (25%), and woven Dacron in 4 (10%; Fig 4) . Endarterectomy for an ulcerated subclavian artery plaque was performed in one patient, and suture repair for a pseudoaneurysm was performed in another. Seven patients (17%) underwent concomitant axillary or brachial artery thromboembolectomy at the time of subclavian artery reconstruction, but no thrombolytic agents were administered intraoperatively because of the risk of bleeding (Table IV) . Twelve patients (30%) had no subclavian artery reconstruction, undergoing observation alone for a mild extent (<100%) of poststenotic dilatation.
Clinical follow-up. Mean postoperative length of stay was 5.4 6 0.6 days, with no difference between patients with a vascular (5.3 6 0.6 days) or a nonvascular (5.4 6 1.2 days) presentation. One patient (2%) died of sepsis from an unrelated condition #30 days of surgical treatment. One patient was readmitted #2 weeks of surgery for nausea and insufficient postoperative pain control, but there were no other early postoperative complications.
During a mean follow-up of 4.5 6 0.4 years (median, 4.3 years; range, 0.9-8.1 years), there were no deaths or amputations. Two of the 26 patients who underwent subclavian artery bypass graft reconstruction required subsequent balloon angioplasty for an anastomotic stenosis identified on follow-up arteriography, and two other patients underwent operative revision for an occluded bypass graft (Table IV) . At the end of followup, the subclavian artery was patent in 38 patients (92%), with three having had bypass graft occlusion (Table IV) . These three individuals had a complicated vascular presentation upon referral: one with previous brachial artery thromboembolism and treatment with multiple subclavian artery stents, one with recent brachial artery thromboembolectomy and occlusion of a previous subclavian artery bypass graft, and one with several years of arm symptoms caused by chronic thromboembolism and a recent posterior stroke. Each of these patients underwent thoracic outlet decompression with a subclavian artery bypass, of which two eventually required further reoperations for bypass graft occlusion (one successful, one with later rethrombosis). No other patients had bypass graft stenosis or occlusion, further subclavian artery dilatation, or thromboembolism. Chronic symptoms were present in six patients (15%), four with longstanding postischemic symptoms in the hand despite revascularization and two with symptoms of neurogenic TOS. (Table V; Fig 5) . By these measures, patients presenting with vascular complications also had a consistently higher level of disability than patients with a nonvascular presentation (QuickDASH score: 47.6 6 4.9 vs 27.3 6 4.8, P ¼ .0056; CBSQ score: 53.8 6 7.6 vs 32.1 6 5.9, P ¼ .0316).
Functional outcomes measures were markedly improved during postoperative follow-up for the overall group and also for patients with vascular and nonvascular presentations (Table V; Fig 5) . Thus, QuickDASH scores for the entire group were 44% 6 12% lower at follow-up than before surgical treatment, and CBSQ scores were 59% 6 9% lower. McGill Pain scores were more variable and not affected as substantially, with scores at follow-up 38% 6 17% lower than before surgical treatment for the entire group, but there were no differences for this measure between the vascular and nonvascular subgroups.
DISCUSSION
In this study we used a relatively strict definition of arterial TOS, with inclusion criteria requiring the presence of a bony abnormality within the thoracic outlet and overt pathology of the subclavian artery. 5 In the past, broader definitions of arterial TOS have often included patients with neurogenic upper extremity symptoms (pain, numbness, and paresthesia) along with positional Dilatation <100% 2 (9) 9 (53) 11 (27) Patent previous bypass 1 (4)
Ulcerated plaque 1 (4) 0 (0) 1 (3) compression of the subclavian artery on physical examination, vascular laboratory tests, or imaging studies. 15 However, even in the presence of a bony abnormality, symptoms in patients without subclavian artery pathology are more readily attributable to brachial plexus compression rather than to any significant degree of arterial insufficiency caused by the transient subclavian artery obstruction that occurs with positional compression. Management in such patients is more appropriately directed toward neurogenic TOS than toward alleviating positional subclavian artery compression. Some patients with longstanding and severe neurogenic TOS also exhibit intermittent digital paresthesia, discoloration, and cold sensation in the absence of a bony abnormality, (9) 2 (12) 4 (10) Endarterectomy alone 1 (4) 0 (0) 1 (2) Suture repair alone 0 (0) 1 (6) 1 (2) Observation alone 3 (13) 9 (53) 12 (30) a Continuous data are presented as the mean 6 standard error of the mean and categoric data as number (%). b DuPont, Wilmington, Del. aneurysm is demonstrated after scalenectomy and resection of the cervical and first ribs. After mobilization of the distal artery into the supraclavicular exposure, clamps were placed and the aneurysmal segment was excised in preparation for an interposition bypass using a cryopreserved femoral artery graft. B, Distal anastomosis. C, Proximal anastomosis. D, Completed bypass graft. BP, Brachial plexus; Clav, clavicle.
thromboembolism, or overt subclavian artery pathology.
Clinical and imaging evaluations demonstrate that these individuals most typically have sympathetic-mediated vasospasm related to chronic brachial plexus nerve compression rather than authentic arterial TOS. 23, 24 This study also excluded patients with distal axillary artery compression at the level of the humeral head, a condition that we have described previously as almost exclusively occurring in high-performance overhead athletes. 25 Axillary artery and branch vessel lesions in this condition can produce thromboembolic complications similar to those observed in arterial TOS, but this is a separate disorder with different implications for surgical treatment. Distinguishing between these various clinical presentations remains an important aspect of evaluation in patients with different forms of TOS and in interpreting the results of clinical management. The present study demonstrates excellent clinical outcomes using standardized evaluation and protocol-driven treatment strategies for arterial TOS, which is emphasized in our multidisciplinary center approach to all forms of TOS that integrates expertise in vascular surgery, physical therapy, pain management, interventional radiology, and other specialties.
Like others, we have found that patients with arterial TOS can be readily separated into two patterns of clinical presentation by the presence or absence of vascular complications. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Patients with a nonvascular presentation may be further divided into those with symptoms attributable to neurogenic TOS and those who are completely asymptomatic. Surgery may be indicated in these patients for the treatment of neurogenic TOS unresponsive to conservative management or for the prevention of subclavian artery complications in those with poststenotic dilatation. A high index of suspicion for subclavian artery pathology should be applied to patients with a cervical rib or first rib anomaly, where definitive imaging by contrast-enhanced CT, magnetic However, routine imaging beyond plain radiographs does not appear necessary in all patients with neurogenic TOS, where the likelihood of identifying fixed subclavian artery pathology is extremely low in the absence of a bony abnormality. Furthermore, noninvasive vascular laboratory studies and duplex imaging do not appear to offer sufficient accuracy or consistency to be useful in evaluating patients with neurogenic TOS or those with suspected arterial TOS. Noteworthy in this study was that 53% of patients with a nonvascular presentation and preoperative subclavian artery dilatation had dilatation of <100% at the time of surgical treatment and thus did not undergo arterial reconstruction compared with only 13% of patients with a vascular presentation. Long-term follow-up in those not having arterial reconstruction revealed no further dilatation or vascular complications, indicating that thoracic outlet decompression alone is sufficient to prevent progression of subclavian artery pathology in this situation. We recommend that such patients undergo periodic follow-up imaging with MRA or CTA to monitor for dilatation in the first few years, but this is probably not needed beyond 3 to 5 years of surgical treatment.
Patients with a vascular presentation of arterial TOS have the greatest potential for disability and poor outcomes, which are usually dictated by the extent of distal thromboembolism and ischemia before surgical treatment. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] We have recommended that when feasible, those with acute or subacute upper extremity ischemia initially undergo surgical treatment for distal thromboembolism, followed by anticoagulation. Any additional imaging evaluation is then performed, followed by staged surgical treatment for arterial TOS as a secondary procedure, days to weeks after thromboembolectomy. This approach was illustrated by eight patients in the present study, representing 38% of those presenting with thromboembolism, whereas the remainder presented with chronic digital ischemia or emboli not amenable to thromboembolectomy. We also had two patients in this series who presented with posterior cerebral stroke as a result of retrograde thromboembolism from the subclavian artery, along with upper extremity symptoms. Posterior stroke is the most devastating vascular complication of arterial TOS and must be kept in mind during diagnostic evaluation and treatment planning. 26, 27 In addition to supraclavicular thoracic outlet decompression, 26 patients underwent subclavian artery reconstruction with an interposition bypass graft. This was usually conducted from the supraclavicular exposure alone, but when necessary, an infraclavicular incision was added to obtain distal control of the axillary artery. Our preference in this series was to use biological conduits, such as cryopreserved femoral artery or vein, for subclavian revascularization given the ease of use and flexibility of these conduits and the recognition that bypass grafts in this location are subject to a high degree of motion with use of the upper extremity.
It has also been our practice to obtain routine intraoperative arteriography to assess the subclavian artery reconstruction. During follow-up we found acceptable patency rates with subclavian bypass grafts in this series, but several patients exhibited bypass graft occlusion. Each of these individuals had a complicated vascular presentation, and two had previously undergone subclavian artery revascularization elsewhere before referral, emphasizing the management challenges presented by some patients with arterial TOS.
CONCLUSIONS
Arterial TOS is a rare condition with the potential for life-and limb-threatening thromboembolic complications. This single-institution series demonstrates the diverse clinical presentation of arterial TOS coincident with a wide spectrum of bony and arterial pathology. This study also indicates that current surgical protocols can achieve excellent outcomes for this frequently complicated subset of patients.
